Stockreport

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share [CNBC]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Tom Little | Reuters The Food and Drug Administration on Thursday approved a higher dose version of Novo Nordisk 's blockbuster weight loss injection Wegovy, as the c [Read more]